Sign In
Buy RHHVF
$411.25
+0 (+0%)
At Close: Jun 22, 2026
Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
02:04am, Thursday, 07'th May 2026
The deal seeks to bolster the artificial-intelligence offerings of Roche's diagnostics division, helping to accelerate clinical-therapy development.
Switzerland's Roche agrees to acquire US-based PathAI
01:51am, Thursday, 07'th May 2026
Swiss pharmaceutical giant Roche said on Thursday it had agreed to acquire U.S.-based digital pathology and AI-powered technology firm PathAI in a deal worth $750 million upfront plus further
Roche: Policy Overhang Clears, Fundamentals Intact, Upside Remains Limited But Positive
10:08am, Tuesday, 28'th Apr 2026
US healthcare policy overhang has largely abated after MFN pricing deals, improving sector sentiment and reducing drug pricing risk for Roche and peers. Q1 showed solid underlying growth (+6% CER), su
Iran won't give up its “new nuclear weapon” - the Strait of Hormuz: David Roche
02:51am, Thursday, 23'rd Apr 2026
David Roche of Quantum Strategy warns of a 3% global economic decline as tankers halt movement through the Gulf and Red Sea. He further argues that markets are disconnected from reality, underestimati
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
02:50am, Thursday, 23'rd Apr 2026
Roche sales fell 5% in the first quarter, but increased 6% in constant exchange rates. The appreciation of the Swiss franc against most currencies, notably the U.S. dollar, had a significant impact on
Roche Backs Full-Year View as Quarterly Sales Rise
01:33am, Thursday, 23'rd Apr 2026
Roche confirmed its full-year guidance after reporting a first-quarter rise in sales driven by high demand for its innovative medicines and diagnostics.
Roche Q1 sales down on forex effects
01:12am, Thursday, 23'rd Apr 2026
Swiss drugmaker Roche said on Thursday that its first-quarter sales declined because of negative foreign exchange effects but rose at constant exchange rates.
Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
01:25am, Wednesday, 22'nd Apr 2026
Swiss drugmaker Roche on Wednesday said it was submitting its experimental multiple sclerosis drug fenebrutinib to global regulators after meeting late-stage trial goals while data released on Wedn
Roche launches new Elevidys study after feedback from European regulator
07:25am, Thursday, 16'th Apr 2026
Roche on Thursday said it is initiating a late stage study for its gene therapy Elevidys following feedback from the European drug regulator. The therapy for duchenne muscular dystrophy (DMD), f
C4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billion
09:34am, Thursday, 09'th Apr 2026
C4 Therapeutics said on Thursday it has entered into a deal focused on research and development of a type of cancer drug with Swiss drugmaker Roche that could be worth more than $1 billion.
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics
09:42am, Tuesday, 07'th Apr 2026
ALLENTOWN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine today announced a preferred partnership with Roche Diagnostics.
Roche (OTCMKTS:RHHVF) Trading 0.4% Higher – Here’s What Happened
05:18am, Thursday, 12'th Feb 2026
Roche Holding AG (OTCMKTS:RHHVF - Get Free Report) rose 0.4% during mid-day trading on Wednesday. The stock traded as high as $473.23 and last traded at $466.69. Approximately 61,765 shares traded han
